Peptide-metal ion pharmaceutical constructs and applications

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 934, 530300, 530330, 530334, 530338, 530333, A61K 5108, A61K 3800, A61B 5055

Patent

active

058914188

ABSTRACT:
A peptide is provided for use as a diagnostic imaging, radiotherapeutic, or therapeutic agent, which peptide has a conformationally constrained global secondary structure obtained upon complexing with a metal ion. The peptide is of the general formula:

REFERENCES:
patent: 4390528 (1983-06-01), Najjar
patent: 4427646 (1984-01-01), Olexa et al.
patent: 4479930 (1984-10-01), Hnatowich
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4650787 (1987-03-01), Schally et al.
patent: 4668503 (1987-05-01), Hnatowich
patent: 4680276 (1987-07-01), Bach et al.
patent: 4732864 (1988-03-01), Tolman
patent: 4849505 (1989-07-01), Stavrianopoulos
patent: 4859765 (1989-08-01), Nester et al.
patent: 4863898 (1989-09-01), Ashmead et al.
patent: 4883861 (1989-11-01), Grill et al.
patent: 4986979 (1991-01-01), Morgan et al.
patent: 5023237 (1991-06-01), Pickart
patent: 5028593 (1991-07-01), Nishioka
patent: 5053393 (1991-10-01), Tjoeng et al.
patent: 5059588 (1991-10-01), Pickart
patent: 5091176 (1992-02-01), Braatz et al.
patent: 5118665 (1992-06-01), Pickart
patent: 5157023 (1992-10-01), Lipton
patent: 5196510 (1993-03-01), Rodwell et al.
patent: 5200504 (1993-04-01), Ghadiri
patent: 5214131 (1993-05-01), Maeda et al.
patent: 5225180 (1993-07-01), Dean et al.
patent: 5266327 (1993-11-01), Agrez
patent: 5323840 (1994-06-01), Coller
patent: 5371184 (1994-12-01), Rajagopalan et al.
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5395609 (1995-03-01), Stuttle
patent: 5408036 (1995-04-01), Ghadiri
patent: 5410020 (1995-04-01), Ghadiri
patent: 5438119 (1995-08-01), Rutter et al.
patent: 5440013 (1995-08-01), Kahn
patent: 5443815 (1995-08-01), Dean et al.
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5464934 (1995-11-01), Dunn et al.
patent: 5470753 (1995-11-01), Sepetov et al.
patent: 5475085 (1995-12-01), Kahn
patent: 5480970 (1996-01-01), Pollak et al.
patent: 5556609 (1996-09-01), Zamora
patent: 5567408 (1996-10-01), Zamora
patent: 5569745 (1996-10-01), Goodbody et al.
patent: 5659041 (1997-08-01), Pollak et al.
patent: 5670133 (1997-09-01), Zamora
patent: 5679642 (1997-10-01), Goodbody et al.
Fischman AJ, Babich JW, Strauss HW: A Ticket to Ride: Peptide Radiopharmaceuticals. J Nucl Med 34:2253-2263, 1993.
Fischman AJ, Pike MC, Kroon D, Fucello AJ, Rexinger D, tenKate C, Wilkinson R, Rubin RH and Strauss HW: Imaging focal sites of bacterial infection in rats with indium-111-labeled chemotactic peptide analogs. J Nucl Med 32:483-491, 1991.
Janeczek AH, Marasco WA, Van Alten PJ and Walter RB: Autoradiographic analysis of formylpeptide chemoattractant binding, uptaking and intracellular processing by neutrophils, J Cell Sci 94:155-168, 1989.
Babich JW, Graham W, Barrow SA, Dragotakes SC, Tompkins RG, Rubin RH and Fischman AJ: Technetium-99m-labeled chemotactic peptides: comparison with Indium-111-labeled white blood cells for localizing acute bacterial infection in the rabbit. J Nucl Med 34:2176-2181, 1993.
Imura Y, Stassen J-M, Dunting S, Stockmans F, and Collen D: Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in hamster platelet-rich femoral vein thrombosis model, Blood 80:1247-1253, 1992.
Knight LC, Radcliffe R, Maurer AH, Rodwell JD and Alvarez VL: Thrombus imaging with Tc-99m synthetic peptides based upon the binding domain of a monoclonal antibody to activated platelets. J Nucl Med 35:282-288, 1994.
Swanson D, Epperly M, Brown ML et al: In-111 laminin peptide fragments for malignant tumor detection. J Nucl Med 34:231P, 1993 (Abstract).
Wraight EP, Bard DR, Maughan TS et al: The Use of A Chelating Derivative of Alpha Melanocyte Stimulating Hormone for the Clinical Imaging of Malignant Melanoma, Br J Radiology 65:112-118, 1992.
Bard DR, Wraight EP, Knight CG: BisMSH-DTPA: a potential imaging agent for malignant melanoma, Ann NY Acad Sci 680:451-453, 1993.
Chou PY and Fasman GD: Prediction of the secondary structure of proteins from their amino acid sequence. In Advances in Enzymology, vol. 47 (1978) pp. 45-145, John Wiley & Sons, New York.
Hruby VJ: Conformational restrictions of biologically active peptides via amino acid side chain groups. Life Sciences 31:189-199, 1981.
Hruby VJ, Sharma SD, Collins N, Matsunaga TO and Russel KC: Synthetic Peptides, A User's Guide (selected portions), Grant GA, editor, W.H. Freedman and Company, 1992, pp. 259-345, 11-24, 24-33, 39-41, and 58-67.
Vallee BL and Auld DS: Zinc coordination, function, and structure of zinc enzymes and other proteins, Biochemistry 29:5648-5659, 1990.
Rhodes D and Klug A: Zinc fingers. Scientific American 268(2):56-65, 1993.
Krizek BA, Amann BT, Kilfoil VJ, Merkle DL, and Berg JM: A consensus zinc finger peptide: Design, high affinity metal binding, a pH-dependent structure, and a His to Cys sequence variant. J. Amer. Chem Soc. 113:4518-4523, 1991.
Shaw GS, Hodges RS, Sykes BD: Calcium-induced peptide association to form an intact protein domain: 1H NMR structural evidence. Science 249:280-283, 1990.
Reid RE, Gariepy J, Saund AK, Hodges RS: Calcium-Induced Protein Folding, J. Biol. Chem. 256:2742, 1981.
Lieberman M, Sasaki T: Iron(II) Organizes a Synthetic Peptide into Three-Helix Bundles, J. Am. Chem. Soc. 113:1470-1471, 1991.
Hruby VJ, Al-obeidi F and Kazmierski W: Emerging approaches in the molecular design of receptor-selective peptide ligands; conformational, topographical and dynamic consideration, Biochem. J. 268:249-262, 1990.
Toniolo C: Conformationally restricted peptides through short-range cyclization, Int. J. Peptide Protein Res. 35:287-300, 1990.
Ozeki E, Kimura S, and Imanishi Y: Conformation and Complexation with Metal Ions of Cyclic Hexapeptides: Cyclo (L-Lue-L-Phe-L-Pro).sub.2 and Cyclo 1989.
Garcia-Escheverria C, Albericio F, Giralt E and Pons M: J. Amer. Chem. Soc., 115:11663-11670, 1992.
Chi DY, O'Neil JP, Anderson CJ, Welch MJ, and Katzenellenbogen JA: Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V): Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones. J. Med. Chem. 37:928-937, 1994.
Schwyzer R: Peptide-membrane interactions and a new principle in quantitative structure-activity relationships, Biopolymers 31:875-792, 1991.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptide-metal ion pharmaceutical constructs and applications does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide-metal ion pharmaceutical constructs and applications, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide-metal ion pharmaceutical constructs and applications will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1368530

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.